The spectrum of dilated cardiomyopathy - The Johns Hopkins experience with 1,278 patients
The spectrum of dilated cardiomyopathy - The Johns Hopkins experience with 1,278 patients
复制标题
DOI:
10.1097/00005792-199907000-00005
复制
发表时间:
1999-07-01
期刊:
影响因子:
1.6
通讯作者:
Kasper, EK
中科院分区:
文献类型:
--
作者:
Felker, GM;Hu, WM;Kasper, EK
Dilated cardiomyopathy, defined as left ventricular systolic dysfunction with chamber dilation, represents a final common pathway for many pathologic cardiac processes. The potential etiologies of dilated cardiomyopathy are numerous. At least 75 specific diseases of heart muscle can result in left ventricular systolic dysfunction, with or without the clinical syndrome of congestive heartfailure (67). Although multiple causes of dilated cardiomyopathy have been described, no clear etiology can beidentified in a substantial percentage of cases (31). While endomyocardial biopsy can be helpful in defining the etiology of dilated cardiomyopathy in some patients, the therapeutic and prognostic utility ofidentifying a specific cause for a given patient remains unclear (38, 40). We report the results of the diagnostic evaluation of a series of 1,278 patients with cardiomyopathy referred to the Johns Hopkins Cardiomyopathy Service between December 29, 1982, and September 1, 1998. The aims of this study are to describe the etiology of cardiomyopathy in a large referral series and to identify specific clinical situations in which endomyocardial biopsy may be usefulin the diagnostic evaluation of these patients. Of these cases, 672 have been reported previously (31).